Header Logo

OWEN MUIR

TitleClinical Assistant Professor
InstitutionBaylor College of Medicine
DepartmentDepartment of Psychiatry & Behavioral Sciences
AddressOne Baylor Plaza
Houston, TX 77030
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Beutler BD, Shinozuka K, Tabaac BJ, Arenas A, Cherian K, Evans VD, Fasano C, Muir OS. Psychedelic Therapy: A Primer for Primary Care Clinicians-Lysergic Acid Diethylamide (LSD). Am J Ther. 2024 Mar-Apr 01; 31(2):e104-e111. PMID: 38518267.
      Citations:    Fields:    
    2. Shinozuka K, Tabaac BJ, Arenas A, Beutler BD, Cherian K, Evans VD, Fasano C, Muir OS. Psychedelic Therapy: A Primer for Primary Care Clinicians-N,N-Dimethyltryptamine and Ayahuasca. Am J Ther. 2024 Mar-Apr 01; 31(2):e112-e120. PMID: 38518268.
      Citations:    Fields:    
    3. Shinozuka K, Tabaac BJ, Arenas A, Beutler BD, Cherian K, Evans VD, Fasano C, Muir OS. Psychedelic Therapy: A Primer for Primary Care Clinicians-3,4-Methylenedioxy-methamphetamine (MDMA). Am J Ther. 2024 Mar-Apr 01; 31(2):e141-e154. PMID: 38518271.
      Citations:    Fields:    
    4. Cherian K, Shinozuka K, Tabaac BJ, Arenas A, Beutler BD, Evans VD, Fasano C, Muir OS. Psychedelic Therapy: A Primer for Primary Care Clinicians-Ibogaine. Am J Ther. 2024 Mar-Apr 01; 31(2):e133-e140. PMID: 38518270.
      Citations:    Fields:    
    5. Muir OS, Shinozuka K, Beutler BD, Arenas A, Cherian K, Evans VD, Fasano C, Tabaac BJ. Psychedelic Therapy: A Primer for Primary Care Clinicians-The Strengths, Weaknesses, Opportunities, and Threats of Psychedelic Therapeutics. Am J Ther. 2024 Mar-Apr 01; 31(2):e178-e182. PMID: 38518273.
      Citations:    Fields:    Translation:Humans
    6. Tabaac BJ, Shinozuka K, Arenas A, Beutler BD, Cherian K, Evans VD, Fasano C, Muir OS. Psychedelic Therapy: A Primer for Primary Care Clinicians-Psilocybin. Am J Ther. 2024 Mar-Apr 01; 31(2):e121-e132. PMID: 38518269.
      Citations:    Fields:    Translation:Humans
    7. Evans VD, Arenas A, Shinozuka K, Tabaac BJ, Beutler BD, Cherian K, Fasano C, Muir OS. Psychedelic Therapy: A Primer for Primary Care Clinicians-Ketamine. Am J Ther. 2024 Mar-Apr 01; 31(2):e155-e177. PMID: 38518272.
      Citations:    Fields:    Translation:Humans
    8. Tabaac BJ, Shinozuka K, Arenas A, Beutler BD, Cherian K, Evans VD, Fasano C, Muir OS. Psychedelic Therapy: A Primer for Primary Care Clinicians-Historical Perspective and Overview. Am J Ther. 2024 Mar-Apr 01; 31(2):e97-e103. PMID: 38518266.
      Citations:    Fields:    
    9. Solomon TM, Hajduk M, Majernik M, Jemison J, Deschamps A, Scoggins J, Kolar A, Pinheiro MA, Dubec P, Skala O, Muir O, Tinkelman A, Karlin DR, Barrow R. Evaluating passive physiological data collection during Spravato treatment. Front Digit Health. 2023; 5:1281529. PMID: 38094111; PMCID: PMC10716422.
      Citations:    
    10. Roth Y, Hanlon CA, Pell G, Zibman S, Harmelech T, Muir OS, MacMillan C, Prestley T, Purselle DC, Knightly T, Tendler A. Real world efficacy and safety of various accelerated deep TMS protocols for major depression. Psychiatry Res. 2023 Oct; 328:115482. PMID: 37738684.
      Citations: 2     Fields:    
    11. Tendler A, Goerigk S, Zibman S, Ouaknine S, Harmelech T, Pell GS, Zangen A, Harvey SA, Grammer G, Stehberg J, Adefolarin O, Muir O, MacMillan C, Ghelber D, Duffy W, Mania I, Faruqui Z, Munasifi F, Antin T, Padberg F, Roth Y. Deep TMS H1 Coil treatment for depression: Results from a large post marketing data analysis. Psychiatry Res. 2023 06; 324:115179. PMID: 37030054.
      Citations:    Fields:    Translation:HumansCTClinical Trials
    12. Harmelech T, Tendler A, Vidrine R, Muir O, MacMillan C, Sinclair R, Shakir S, Kent D, Evangelidis N, Roth Y, Arikan MK, ?etin HL, Esmeray MT, Ilhan R. Long-term outcomes of a course of deep TMS for treatment-resistant OCD. Brain Stimul. 2022 Jan-Feb; 15(1):226-228. PMID: 34982981.
      Citations:    Fields:    Translation:Humans
    13. Muir O, Weinfeld JN, Ruiz D, Ostrovsky D, Fiolhais M, MacMillan C. Mental health clinicians' attitudes toward narcissistic personality disorder. Personal Disord. 2021 09; 12(5):389-399. PMID: 34793187.
      Citations:    Fields:    Translation:Humans
    14. Roth Y, Tendler A, Vidrine R, Kent D, Muir O, MacMillan C, Casuto L, Grammer G, Sauve W, Tolin K, Harvey S, Borst M, Rifkin R, Sheth M, Cornejo B, Rodriguez R, Shakir S, Porter T, Kim D, Peterson B, Swofford J, Roe B, Sinclair R, Harmelech T, Zangen A, Arikan MK. Real-world efficacy of deep TMS for obsessive-compulsive disorder: Post-marketing data collected from twenty-two clinical sites. J Psychiatr Res. 2021 05; 137:667-672. PMID: 33183769.
      Citations: 4     Fields:    Translation:Humans
    15. Peek HS, Richards M, Muir O, Chan SR, Caton M, MacMillan C. Blogging and Social Media for Mental Health Education and Advocacy: a Review for Psychiatrists. Curr Psychiatry Rep. 2015 Nov; 17(11):88. PMID: 26377948.
      Citations: 9     Fields:    Translation:Humans
    16. Manu P, Sarpal D, Muir O, Kane JM, Correll CU. When can patients with potentially life-threatening adverse effects be rechallenged with clozapine? A systematic review of the published literature. Schizophr Res. 2012 Feb; 134(2-3):180-6. PMID: 22113154; PMCID: PMC3318984.
      Citations: 41     Fields:    Translation:Humans
    MUIR's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (61)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _